Tudor Investment Corp’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,141
| Closed | -$638K | – | 1665 |
|
|
2025
Q1 | $638K | Buy |
35,141
+2,596
| +8% | +$47.1K | ﹤0.01% | 1152 |
|
|
2024
Q4 | $822K | Buy |
+32,545
| New | +$822K | ﹤0.01% | 1070 |
|
|
2024
Q2 | – | Sell |
-67,384
| Closed | -$2.83M | – | 1563 |
|
|
2024
Q1 | $2.83M | Buy |
67,384
+52,842
| +363% | +$2.22M | 0.02% | 568 |
|
|
2023
Q4 | $577K | Sell |
14,542
-7,496
| -34% | -$297K | ﹤0.01% | 1100 |
|
|
2023
Q3 | $606K | Sell |
22,038
-1,637
| -7% | -$45.1K | 0.01% | 1065 |
|
|
2023
Q2 | $803K | Sell |
23,675
-3,600
| -13% | -$122K | 0.01% | 977 |
|
|
2023
Q1 | $981K | Buy |
+27,275
| New | +$981K | 0.02% | 920 |
|
|
2019
Q1 | – | Sell |
-4,363
| Closed | -$13K | – | 1103 |
|
|
2018
Q4 | $13K | Hold |
4,363
| – | – | ﹤0.01% | 963 |
|
|
2018
Q3 | $30K | Hold |
4,363
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q2 | $33K | Sell |
4,363
-1,404
| -24% | -$10.6K | ﹤0.01% | 994 |
|
|
2018
Q1 | $202K | Sell |
5,767
-1,088
| -16% | -$38.1K | 0.01% | 855 |
|
|
2017
Q4 | $292K | Buy |
6,855
+2,878
| +72% | +$123K | 0.01% | 805 |
|
|
2017
Q3 | $171K | Buy |
3,977
+3,010
| +311% | +$129K | ﹤0.01% | 968 |
|
|
2017
Q2 | $36K | Buy |
+967
| New | +$36K | ﹤0.01% | 978 |
|
|
2017
Q1 | – | Sell |
-3,187
| Closed | -$169K | – | 1381 |
|
|
2016
Q4 | $169K | Buy |
3,187
+2,293
| +256% | +$122K | ﹤0.01% | 1232 |
|
|
2016
Q3 | $54K | Sell |
894
-115
| -11% | -$6.95K | ﹤0.01% | 1352 |
|
|
2016
Q2 | $66K | Sell |
1,009
-8,287
| -89% | -$542K | ﹤0.01% | 1369 |
|
|
2016
Q1 | $527K | Buy |
9,296
+8,239
| +779% | +$467K | 0.01% | 717 |
|
|
2015
Q4 | $249K | Buy |
+1,057
| New | +$249K | 0.01% | 1178 |
|
|
2015
Q2 | – | Sell |
-1,887
| Closed | -$789K | – | 1470 |
|
|
2015
Q1 | $789K | Buy |
+1,887
| New | +$789K | 0.03% | 470 |
|